Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis
Neurosurgical Focus · 2024
DOI: 10.3171/2024.8.focus24457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Focus, 2024. Verfasst von Adham M Khalafallah und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami; and. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Laser Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE Laser interstitial thermal therapy (LITT) has emerged as an alternative for treating glioblastoma (GBM) in patients deemed unsuitable for resection due to deep-seated or eloquent location, age, or comorbidities. However, its safety and efficacy in large-volume, deep-seated, newly diagnosed GBM (nGBM) tumors remain insufficiently studied. Therefore, the authors aimed to assess the outcomes of LITT in the treatment of deep-seated, large-volume nGBM. METHODS A retrospective analysis of patients with nGBM who underwent LITT between February 2013 and August 2023 was conducted. Patients with deep-seated tumor volume ≥ 10 cm 3 treated with LITT were compared to patients with deep-seated tumor volume < 10 cm 3 . Demographic, perioperative, and follow-up data were collected and compared among both groups. Kaplan-Meier survival analysis and Cox proportional hazards regression were performed to evaluate the impact of various clinical and treatment-related factors on patient survival. RESULTS A total of 33 patients in the study group (mean ± SD age 65.7 ± 10.2 years, 58% male) with mean tumor volume 36.0 ± 21.6 cm 3 were compared to 23 controls (mean age 67.0 ± 12.5 years, 61% male) with mean tumor volume 5.2 ± 2.7 cm 3 . There were no significant differences in hospital length of stay (p = 0.494), temporary neurological deficits and edema within 30 days (p = 0.705 and p > 0.999, respectively), 30-day readmissions (p = 0.139), < 30-day complications (p = 0.918), complications between 30 days and 3 months (p = 0.903), and new motor and speech deficits within 3 months (p = 0.883 and p > 0.999, respectively) between the study and control groups. Kaplan-Meier analysis did not reveal any statistically significant difference in overall survival (OS) between groups (p = 0.227). Multivariate analysis indicated that tumor volume did not significantly affect the hazard ratio for individuals undergoing LITT (HR 1.16, 95% CI 0.83–3.29, p = 0.150). CONCLUSIONS This pilot study suggests that LITT is safe for treating patients with large-volume, deep-seated nGBM compared to those with small-volume tumor. Although there appears to be improved OS in patients with smaller lesions with greater EOA, significance was not achieved in this cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami; and.
- 2Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida.
Zitieren
APA
Khalafallah, A. M., Shah, K. H., Knott, M. V., Berke, C. N., Shah, A. H., Komotar, R. J., & Ivan, M. E. (2024). Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis. Neurosurgical Focus. https://doi.org/10.3171/2024.8.focus24457
Vancouver
Khalafallah AM, Shah KH, Knott MV, Berke CN, Shah AH, Komotar RJ, et al. Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis. Neurosurgical Focus. 2024. doi:10.3171/2024.8.focus24457
BibTeX
@article{Khalafallah2024,
author = {Khalafallah, Adham M and Shah, Khushi H and Knott, Maxon V and Berke, Chandler N and Shah, Ashish H and Komotar, Ricardo J and Ivan, Michael E},
title = {Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis},
journal = {Neurosurgical Focus},
year = {2024},
doi = {10.3171/2024.8.focus24457}
}
EUVIMED